Marsh Elder Allergy Shots (SCIT)
Marsh elder allergy shots (SCIT) target the under-recognized fourth ragweed of the Midwest and Mississippi Delta — Iva annua, a member of subtribe Ambrosiinae whose Amb a 1 pectate lyase cross-reactivity with true ragweeds means it functionally adds to the Ambrosia allergenic complex.
Marsh Elder Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to marsh elder — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of marsh elder allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of marsh elder immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of marsh elder extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for marsh elder allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing marsh elder extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription marsh elder immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat marsh elder allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Marsh Elder?
The biology, taxonomy, and clinical fingerprint of Marsh Elder — the foundation of how SCIT targets it.
Iva annua (marsh elder / sumpweed) colonizes river bottoms, wetland edges, and disturbed ground across the Mississippi Delta and southern Plains — its pollen is morphologically indistinguishable from ragweed and frequently miscounted in aerobiological monitoring
- Scientific name
- Iva annua
- Family
- AsteraceaeComposite / Daisy family
- Type
- Annual weed pollen
- Native to
- Central and southern Plains, Midwest, and Mississippi River basin — widely distributed across Kansas, Oklahoma, Nebraska, Iowa, Missouri, Arkansas, Mississippi, and Louisiana
- Allergen proteins
- No WHO/IUIS-characterized allergens for Iva annua specificallyExpected Amb a 1 pectate lyase cross-reactivity based on subtribe Ambrosiinae kinship with AmbrosiaImmunoCAP w16 covers Iva xanthiifolia (rough marshelder) — used for serological testing in the Iva genusProfilin and polcalcin pan-allergens presumed present but uncharacterized
- Particle size
- Similar to Ambrosia — morphologically indistinguishable from ragweed pollen under light microscopy
- Avoidance difficulty
- Very difficult
How Marsh Elder Allergy Presents
Symptoms by body system — useful for distinguishing Marsh Elder sensitivity from overlapping allergies and infections.
Respiratory
- Late-summer rhinitis July through October in the Mississippi Delta and southern Plains — often mistakenly attributed entirely to ragweed
- Nasal congestion and sneezing peaking in August–September in Kansas, Oklahoma, Arkansas, and Mississippi
- Persistent symptoms despite Ragwitek or ragweed SCIT — the clinical hallmark of untreated marsh elder co-sensitization
- Allergic asthma exacerbation during peak Iva pollen counts in Delta river-bottom habitats
- Marsh elder documented as rivaling ragweed as the dominant fall aeroallergen in parts of the Mississippi Delta (Wagner et al.)
Ocular
- Allergic conjunctivitis peaking August–September in Delta and southern Plains patients
- Symptoms indistinguishable from ragweed-driven conjunctivitis — differential requires testing
- Bilateral tearing and itching on high-count days in wetland and river-bottom environments
Skin
- Type IV sesquiterpene lactone contact allergy from handling Iva annua leaves and stems (dual-mechanism plant — wind-pollinated IgE aeroallergen AND potential Type IV contact allergen)
- Atopic dermatitis flares during August–October peak season
- OAS via profilin pan-allergen cross-reactivity theoretically possible but uncharacterized
Systemic
- Fatigue and sleep disruption from prolonged uncontrolled fall rhinitis during the August–October peak
- Historical footnote: Iva annua was cultivated as a food crop by Pre-Columbian Eastern North American cultures (Eastern Agricultural Complex) for approximately 2,000 years before maize displaced it — the same wind-pollinated annual that nourished ancient populations now causes fall allergy for their modern counterparts
- Reduced work capacity for Mississippi Delta agricultural workers during harvest season
- Misdiagnosis burden: patients who fail ragweed-only immunotherapy and do not know they are sensitized to marsh elder separately
If your Mississippi Delta patient does three years of standardized ragweed SCIT and still hits a wall every September, marsh elder is almost certainly the missing component — and the pollen on the slides was probably miscounted as ragweed the whole time.
When & Where Marsh Elder Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: mid-August through mid-September in Midwest river valleys and Mississippi Delta· ~10–12 weeks; overlaps entirely with ragweed season — the clinical challenge is distinguishing the two
US Exposure Map
7 high-intensity statesWhat Marsh Elder Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Marsh elder's subtribe Ambrosiinae membership — the same subtribe as Ambrosia (ragweeds) — places it as sister genus to ragweed with expected Amb a 1 pectate lyase cross-reactivity; this makes co-treatment with short ragweed, giant ragweed, and cocklebur in Midwest fall-weed vials clinically rational.
Same genus Iva — highest within-group cross-reactivity; Iva xanthiifolia (ImmunoCAP w16) is the serological reference for the genus
Expected Amb a 1 pectate lyase cross-reactivity via shared subtribe Ambrosiinae — the molecular basis for marsh elder being the 'fourth ragweed'
Sister genus relationship via Miao et al. 2008 phylogenetics; pectate lyase and profilin cross-reactivity
Is SCIT Right for Your Marsh Elder Allergy?
Answer five questions to evaluate whether marsh elder SCIT is appropriate for your Midwest or Mississippi Delta fall allergy profile — particularly if you have persistent symptoms despite ragweed treatment.
Do your fall allergy symptoms persist despite ragweed treatment (Ragwitek, ragweed SCIT, or ragweed SLIT)?
The Marsh Elder SCIT Protocol
Marsh elder SCIT uses non-standardized Iva annua extract (W/V labeled); no WHO/IUIS allergens are characterized for Iva annua specifically, though ImmunoCAP w16 covers Iva xanthiifolia for serological testing across the genus. The extract is typically combined in a Midwest/Delta fall-weed vial with short ragweed, giant ragweed, and cocklebur.
Progressive dose escalation with mandatory 30-minute post-injection observation. Build-up initiated by April or May allows approaching maintenance before late-July onset. Marsh elder is combined with ragweed, giant ragweed, cocklebur, and rough marshelder in the Midwest/Delta fall-weed vial.
Monthly maintenance injections. For Delta patients whose marsh elder sensitization was previously unrecognized despite ragweed treatment, the most meaningful efficacy endpoint is September symptom control — historically the month that ragweed treatment alone failed to control. Improvement typically begins in the first treated season and builds over years two and three.
After successful completion, durable tolerance is expected. Mississippi Delta patients with ongoing river-bottom exposure may benefit from extended maintenance given high cumulative pollen loads.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Marsh Elder SCIT
No published RCT evaluates SCIT specifically for Iva annua. Clinical rationale rests on documented sensitization rates, aerobiological evidence of dominant pollen production in the Mississippi Delta, pectate lyase cross-reactivity data from the Ambrosiinae subtribe, and the general AAAAI/ACAAI Practice Parameter framework for non-standardized weed SCIT.
- Sensitization rate in Mississippi Delta and southern Plains15%Regional NAB / Delta allergy clinic data — 10–20% of fall-symptomatic patients in Mississippi Delta and southern Plains show positive Iva annua reactivity
- Pollen morphological similarity to ragweed (miscounting frequency)90%Mid-South aerobiology literature (Wagner et al.) — Iva pollen is morphologically indistinguishable from Ambrosia pollen under light microscopy, leading to systematic undercounting of marsh elder in traditional aerobiological monitoring and under-recognition of Iva as a primary allergen
No Iva annua-specific SCIT RCT has been published. The clinical case for including marsh elder in Midwest/Delta fall-weed vials is strong: sensitization rates of 10–20%, morphological indistinguishability from ragweed leading to systematic under-diagnosis, documented dominance in the Mississippi Delta rivaling ragweed, and pectate lyase cross-reactivity suggesting molecular overlap with the Ambrosia allergen family. Patients who fail ragweed-only immunotherapy in the Delta or southern Plains should be evaluated for Iva annua sensitization before concluding their immunotherapy has failed.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Marsh Elder SCIT Side Effects
Marsh elder SCIT follows the standard inhalant SCIT safety profile with mandatory 30-minute post-injection observation. The dual mechanism of marsh elder (wind-pollinated IgE aeroallergen AND potential Type IV sesquiterpene lactone contact allergen) does not affect SCIT safety.
Local reactions
4 documentedSystemic reactions
4 documentedMarsh elder SCIT safety is consistent with the general inhalant SCIT record; the sesquiterpene lactone contact allergen component of the plant does not affect the safety profile of pollen extract SCIT administered subcutaneously.
SCIT vs Alternatives for Marsh Elder
Mississippi Delta and southern Plains patients with marsh elder co-sensitization typically receive it as a component of a combined fall-weed SCIT vial (ragweed + marsh elder + giant ragweed + cocklebur) rather than marsh elder SCIT alone.
| Criterion | At-Home SCIT (Curex)Best | SLIT drops/tablets | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Extrapolated — no Iva RCT; Amb a 1 cross-reactivity supports use | Extrapolated evidence base | Very difficult — dominant Delta river-bottom weed | Symptom suppression only |
| 5-yr cost | $3,500–$8,000 out-of-pocket | Daily drops (varies by pharmacy) | Low direct cost | $300–$1,200/year |
| Duration | 3–5 years | 3–5 years | Seasonal | Daily in season |
| Convenience | At-home self-injection; weekly then monthly | Daily drops at home | Restricts outdoor activity Aug–Oct | Convenient but August–October burden |
| Safety | Systemic reaction <0.01%/injection | Lower systemic risk | Complete | Well-tolerated |
| Lasting effect | Durable benefit expected | Durable benefit expected | No lasting effect | No lasting effect |
At-Home SCIT (Curex)Best
SLIT drops/tablets
Avoidance
Medications
For rural Mississippi Delta and Plains residents far from specialist allergy care, Curex offers an at-home allergy shot at $129/month all-inclusive — a personalized serum compounded to USP <797> covering marsh elder alongside short ragweed, giant ragweed, and cocklebur in the complete subtribe Ambrosiinae fall-weed complex that ragweed-only Ragwitek cannot fully address, with a prescribed epinephrine auto-injector confirmed on hand and the first injection plus every dose change supervised live over Zoom by a board-certified allergist.
What Marsh Elder SCIT Actually Costs
Marsh elder SCIT as a component of a Midwest or Delta fall-weed vial is typically covered under standard allergy immunotherapy benefits when a board-certified allergist documents sensitization; coverage depends on individual plan deductible and co-insurance. Curex at-home IgE testing identifies specific marsh elder sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your marsh elder allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Marsh Elder SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Marsh elder (Iva annua, also called sumpweed) is a wind-pollinated annual weed in the same botanical subtribe as ragweeds (subtribe Ambrosiinae, tribe Heliantheae). Molecular phylogenetic studies (Miao et al. 2008) place Iva as sister genus to Ambrosia, meaning marsh elder and ragweed share a close evolutionary ancestor. The expected consequence is Amb a 1 pectate lyase cross-reactivity — the same major allergen that drives ragweed allergy. This makes marsh elder the functional 'fourth ragweed' alongside short ragweed, giant ragweed, and western ragweed in the Midwest and Mississippi Delta fall allergy picture. Clinically, patients with strong marsh elder sensitization show similar symptom profiles to those with primary Ambrosia sensitization, and the two are difficult to distinguish without specific Iva IgE testing.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.